Search results

View (previous 20 | ) (20 | 50 | 100 | 250 | 500)
  • {{Infobox drug ...に送り、試験を行っていたとして、特許を取り消した。したがって、この出来事は、問題の特許を無効にする「公然使用」に該当する。ロバザの[[Generic drug/ja|後発医薬品]]バージョンは2014年4月にアメリカで発売された。 ...
    13 KB (590 words) - 22:14, 15 April 2024
  • {{Short description|Pharmacological drug nomenclature}} ...Medical Association]] | access-date = 22 January 2021 }}</ref> A marketed drug might also have a company code or [[list of pharmaceutical compound number ...
    25 KB (3,297 words) - 17:05, 3 January 2023
  • ...% as unchanged drug); feces (~45%, mostly as metabolites, 12% as unchanged drug) '''Febuxostat''', sold under the brand names ''Uloric'' among others, is a [[medication]] used long-term to treat [[gout ...
    9 KB (1,260 words) - 20:24, 22 April 2024
  • ...% as unchanged drug); feces (~45%, mostly as metabolites, 12% as unchanged drug) '''Febuxostat''', sold under the brand names ''Uloric'' among others, is a [[medication]] used long-term to treat [[gout ...
    9 KB (1,308 words) - 20:19, 22 April 2024
  • {{Infobox drug ...lar drugs. In that same year, Reliant and Pronova won FDA approval for the drug, and it was launched in the US and Europe in 2005. Global sales in 2005 wer ...
    11 KB (1,574 words) - 22:14, 15 April 2024
  • {{Infobox drug ...lar drugs. In that same year, Reliant and Pronova won FDA approval for the drug, and it was launched in the US and Europe in 2005. Global sales in 2005 wer ...
    12 KB (1,634 words) - 22:13, 15 April 2024
  • Benfotiamine is primarily marketed as an [[over-the-counter drug]] to treat diabetic polyneuropathy. A 2021 review described two clinical tr ...nd Vilotram. It was also marketed in some jurisdictions as a [[combination drug]] with [[cyanocobalamin]] as Milgamma, in combination with [[pyridoxine]] a ...
    5 KB (699 words) - 09:19, 3 April 2024
  • {{Pathnav|Medication|Antihypertensive drug|Calcium channel blocker|frame=1}} '''Nifedipine''', sold under the brand names '''Adalat''' and '''Procardia''' among others, is a [[calcium channel block ...
    13 KB (1,794 words) - 21:32, 15 November 2023
  • Benfotiamine is primarily marketed as an [[over-the-counter drug]] to treat diabetic polyneuropathy. A 2021 review described two clinical tr ...nd Vilotram. It was also marketed in some jurisdictions as a [[combination drug]] with [[cyanocobalamin]] as Milgamma, in combination with [[pyridoxine]] a ...
    6 KB (727 words) - 09:19, 3 April 2024
  • The U.S. [[Food and Drug Administration]] (FDA) considers zinc gluconate to be [[generally recognize ...injected directly into the testicles. It has been sold under various brand names, including [[Neutersol]] and Esterilsol. ...
    5 KB (707 words) - 21:59, 20 April 2024
  • '''Sulbutiamine''' (brand names '''Arcalion''', '''Enerion''') is a synthetic derivative of [[thiamine]] (v ...marketed in France by Servier in 1973 under the brand name Arcalion. The drug registration went through a validation procedure in France in the 1980s, wh ...
    5 KB (702 words) - 11:03, 3 April 2024
  • The U.S. [[Food and Drug Administration]] (FDA) considers zinc gluconate to be [[generally recognize ...injected directly into the testicles. It has been sold under various brand names, including [[Neutersol]] and Esterilsol. ...
    5 KB (727 words) - 21:58, 20 April 2024
  • {{Infobox drug | licence_CA = <!-- Health Canada may use generic or brand name (generic name preferred) --> ...
    13 KB (1,826 words) - 22:16, 15 April 2024
  • '''Sulbutiamine''' (brand names '''Arcalion''', '''Enerion''') is a synthetic derivative of [[thiamine]] (v ...marketed in France by Servier in 1973 under the brand name Arcalion. The drug registration went through a validation procedure in France in the 1980s, wh ...
    5 KB (738 words) - 11:00, 3 April 2024
  • {{Infobox drug | licence_CA = <!-- Health Canada may use generic or brand name (generic name preferred) --> ...
    13 KB (1,886 words) - 22:15, 15 April 2024
  • {{Infobox drug '''Insulin glargine''' sold under the brand name '''Lantus''' among others is a long-acting [[insulin analogue|modified ...
    9 KB (1,241 words) - 11:01, 20 March 2024
  • {{Infobox drug '''Insulin glargine''' sold under the brand name '''Lantus''' among others is a long-acting [[insulin analogue|modified ...
    9 KB (1,299 words) - 11:00, 20 March 2024
  • {{Pathnav|Medication|Antihypertensive drug|Calcium channel blocker|frame=1}} '''Nifedipine''', sold under the brand names '''Adalat''' and '''Procardia''' among others, is a [[calcium channel block ...
    13 KB (1,738 words) - 21:46, 15 November 2023
  • {{Drug List/ja|state6=uncollapsed}} ...f patients) than other GLP-1 agonists and can decrease the efficacy of the drug. GLP-1 agonists increase the risk of [[gallstones]] when used to induce rap ...
    13 KB (1,847 words) - 16:47, 13 April 2024
  • {{Infobox drug ==Names== ...
    9 KB (1,264 words) - 22:41, 10 April 2024
View (previous 20 | ) (20 | 50 | 100 | 250 | 500)